{"id":"W3215111763","doi":"10.1016/j.ejca.2021.09.024","title":"KEYNOTE-022: Pembrolizumab with trametinib in patients with BRAF wild-type melanoma or advanced solid tumours irrespective of BRAF mutation","year":2021,"lang":"en","type":"article","venue":"European Journal of Cancer","topic":"Melanoma and MAPK Pathways","field":"Biochemistry, Genetics and Molecular Biology","cited_by":10,"is_retracted":false,"has_abstract":false,"ca_institutions":"Princess Margaret Cancer Centre; McGill University; University of Toronto; Jewish General Hospital; McMaster University; Juravinski Cancer Centre","funders":"","keywords":"Trametinib; Pembrolizumab; Dosing; Medicine; Adverse effect; Internal medicine; Melanoma; Oncology; Immunotherapy; MAPK/ERK pathway; Cancer; Cancer research; Biology; Kinase","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001810655,0.0001586697,0.0002694335,0.0000736254,0.0000290898,0.00001573731,0.0001510137,0.00003178307,0.00005852119],"category_scores_gemma":[0.0001097123,0.0001106899,0.0000583322,0.0002006306,0.00006245159,0.00001691885,0.00003331601,0.0001609172,0.000001699718],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003445665,"about_ca_system_score_gemma":0.0004184844,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000005513683,"about_ca_topic_score_gemma":0.0001288255,"domain_scores_codex":[0.9987153,0.0002371921,0.0003751221,0.0002181912,0.0002691101,0.0001850214],"domain_scores_gemma":[0.9986126,0.00001727055,0.0004593851,0.0001822167,0.0006388084,0.00008969272],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.08881488,0.001763379,0.3894281,0.0002325328,0.001244925,0.004626177,0.003447395,0.01577501,0.3826033,0.00007470843,0.001339665,0.1106499],"study_design_scores_gemma":[0.01335733,0.009827985,0.707846,0.0003790065,0.0001059877,0.0002277455,0.000432088,0.00001044781,0.2631801,0.00001078428,0.004287842,0.000334649],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.997048,0.0007276353,0.0003569797,0.00006869566,0.0001705547,0.0001100543,0.00001874104,0.000002916549,0.001496434],"genre_scores_gemma":[0.998213,0.0001152921,0.001088619,0.00009923812,0.0001463742,0.000001622167,0.00002261589,0.00003979431,0.0002734733],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.3184179,"threshold_uncertainty_score":0.4513804,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.00713408438545517,"score_gpt":0.2450016289339794,"score_spread":0.2378675445485242,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}